MARCUS BOEHM
Profile
First Name
Middle Name
Last Name
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
KRISTINA BUROW,
DOUG COLE,
PAUL GRAYSON,
SHEILA GUJRATHI,
FAHEEM HASNAIN,
CHRYSA MINEO,
AMIR NASHAT,
ROBERT NELSEN,
ROBERT NELSON,
ROBERT PEACH,
WILLIAM RASTETTER,
JAMES SCHMIDT,
MICHAEL SHEFFERY,
RAYMOND STEVENS,
ED TORRES
DIRECTOR
BLAKE ANSON,
DAVID BUCHE,
RYAN GORDON,
KEVIN GUNDERSON,
PAUL HANSEN,
DIMAS JIMENEZ,
MURDOC KHALEGHI,
ANDREW LAFRENCE,
SRIRAM NADATHUR,
PATRICK O-SHAUGHNESSY,
MATTHEW PERIS,
ROBERT PETCAVICH,
STEVEN SNYDER,
YUNG-PING YEH,
FABIAN ZANELLA
EXECUTIVE OFFICER
ALAIN BARON,
KATHLEEN GLAUB,
KATHLEEN SEREDA GLAUB,
JOSHUA GRASS,
JASON HAFLER,
PETER HIRTH,
JEENJOO KANG,
AARON MISHEL,
KEVIN RAIDY,
ANDREW SCHWAB,
ROBERT TJIAN,
CHARLES ZUKER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2022-11-14
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-08-19
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2020-08-19
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-08-08
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
2017-10-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2018-03-23
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2017-10-24
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Equity
2017-02-24
D/A
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-07-22
D
BIOTECHNOLOGY
DECLINE TO DISCLOSE
Debt
2016-07-22
D
PHARMACEUTICALS
NO REVENUES
Equity
2012-02-03
